Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Carling Communications Names Sherri Wilkins Chief Creative Officer

Carling Communications Inc. announced that Sherri Wilkins has been named the agency’s Chief Creative Officer.

Read More »

Amgen cholesterol drug reduces arterial plaque buildup: study

Amgen Inc. said its potent new cholesterol fighter Repatha met the primary and secondary goals of a study designed to show it can decrease plaque buildup in heart arteries of patients already taking widely used statin drugs, such as Lipitor.

Read More »

Pfizer to Shut Down New York Plant, 120 Staffers Affected

Pfizer will exit a site in upstate New York it has operated since 2011. The company expects to shutter the facility in early 2018, displacing about 120 employees, the Press Republican reported.

Read More »

Allergan Buys Tobira for $1.695 Billion

In yet another buy in its string of acquisitions, Dublin-based Allergan announced it was acquiring San Francisco-based Tobira Therapeutics.

Read More »

GSK names insider Emma Walmsley as new CEO

GlaxoSmithKline said it had chosen its head of consumer healthcare, Emma Walmsley, as its new chief executive after several months of reviewing candidates.

Read More »

Teva Forges $2.6 Billion Deal to Buy Into Regeneron’s Pain Drug Fasinumab

Teva Pharmaceutical Industries is banking big time on New York-based Regeneron’s investigational NGF antibody, fasinumab, for the treatment of osteoarthritis pain and low back pain.

Read More »

Bayer raises sales targets for top-selling drugs after Monsanto deal

German drugmaker Bayer said its two best-selling drugs had a higher annual peak sales potential than previously targeted, after the agreed $66 billion takeover of Monsanto stirred criticism it might neglect its pharmaceuticals business.

Read More »

Wearable device helps reduce low blood sugar episodes

A new “flash” blood sugar monitoring system cuts down on episodes of low blood sugar in people with type 1 diabetes, researchers say.

Read More »

Sarepta’s DMD drug wins FDA approval

Sarepta Therapeutics Inc.’s Duchenne muscular dystrophy drug won approval from the U.S. FDA, capping months of regulatory uncertainty.

Read More »

U.S. FDA approves Bayer contraceptive Kyleena

The U.S. Food and Drug Administration approved Bayer AG’s hormonal contraceptive device Kyleena to prevent pregnancy for up to five years.

Read More »

UK Biopharma and life after Brexit

Paul Ranson, of global law firm Morgan Lewis’ London Life Science’s Practice, examines how the UK Biopharma must now adapt to a changing landscape.

Read More »

FDA Places Clinical Hold on AML Drug Co-Developed by Johnson & Johnson and Genmab

Johnson & Johnson has indicated that its acute myeloid leukemia (AML) drug, JNJ-63709178, has been put on clinical hold because of serious side effects.

Read More »

Astellas, Vical herpes vaccine fails mid-stage study

Japan’s Astellas Pharma Inc. and San Diego-based Vical Inc. said their experimental herpes vaccine failed a mid-stage study involving certain kidney transplant patients.

Read More »

Global fund raises $12.9 billion to fight AIDS, TB and malaria

A global fund has raised over $12.9 billion from international donors as part of a campaign aimed at effectively eradicating AIDS, malaria and tuberculosis by 2030, conference organizers said.

Read More »

Novartis says MS drug cut risk of disability advance in study

Novartis’ investigational multiple sclerosis drug cut the risk of disability progression in patients with a tough-to-treat form of the disease versus a placebo, the Swiss company said, citing a new analysis of a late-stage trial.

Read More »

J&J Pays $4.325 Billion for Abbott’s Eye Surgery Biz

Johnson & Johnson announced it will acquire Abbott Medical Optics for more than $4 billion. The deal is expected to close in the first quarter of 2017.

Read More »

U.S. Justice Dept to push prosecutors on opioid crisis – USA Today

The U.S. Justice Department will enlist federal prosecutors to help fight the nation’s opioid crisis by sharing information on overprescribing doctors and coordinating with public health officials to address addiction, USA Today reported.

Read More »

Brain cancer now deadliest for U.S. children: study

Brain cancer is now the deadliest form of childhood cancer in the United States, surpassing leukemia as treatment advances have allowed doctors to cure many blood-related cancers, the Centers for Disease Control and Prevention said.

Read More »

EMA panel recommends nod for Pfizer’s breast cancer drug

U.S. drugmaker Pfizer Inc.’s breast cancer drug Ibrance should be given marketing approval, an advisory committee at the European Medicines Agency recommended.

Read More »

Forxiga combo beats use of drug alone

AstraZeneca said combining its Forxiga diabetes drug with Bydureon was more effective at controlling blood sugar levels than treatment with either drug on its own.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom